This research report focuses on the Pharmacovigilance Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.
TABLE OF CONTENTS
1 Report Business Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Type
- 1.2.1 Global Pharmacovigilance Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
- 1.2.2 Chemotherapy
- 1.2.3 Contract Outsourcing
- 1.3 Market by Application
- 1.3.1 Global Pharmacovigilance Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
- 1.3.2 Pharma and Biotech Companies
- 1.3.3 Contract Research Organizations (CROs)
- 1.3.4 Business Process Outsourcing (BPO) Firms
- 1.3.5 Others
- 1.4 Study Objectives
- 1.5 Years Considered
2 Global Growth Trends
- 2.1 Global Pharmacovigilance Market Perspective (2017-2028)
- 2.2 Pharmacovigilance Growth Trends by Region
- 2.2.1 Pharmacovigilance Market Size by Region: 2017 VS 2021 VS 2028
- 2.2.2 Pharmacovigilance Historic Market Size by Region (2017-2022)
- 2.2.3 Pharmacovigilance Forecasted Market Size by Region (2023-2028)
- 2.3 Pharmacovigilance Market Dynamics
- 2.3.1 Pharmacovigilance Industry Trends
- 2.3.2 Pharmacovigilance Market Drivers
- 2.3.3 Pharmacovigilance Market Challenges
- 2.3.4 Pharmacovigilance Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Top Pharmacovigilance Players by Revenue
- 3.1.1 Global Top Pharmacovigilance Players by Revenue (2017-2022)
- 3.1.2 Global Pharmacovigilance Revenue Market Share by Players (2017-2022)
- 3.2 Global Pharmacovigilance Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.3 Players Covered: Ranking by Pharmacovigilance Revenue
- 3.4 Global Pharmacovigilance Market Concentration Ratio
- 3.4.1 Global Pharmacovigilance Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by Pharmacovigilance Revenue in 2021
- 3.5 Pharmacovigilance Key Players Head office and Area Served
- 3.6 Key Players Pharmacovigilance Product Solution and Service
- 3.7 Date of Enter into Pharmacovigilance Market
- 3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmacovigilance Breakdown Data by Type
- 4.1 Global Pharmacovigilance Historic Market Size by Type (2017-2022)
- 4.2 Global Pharmacovigilance Forecasted Market Size by Type (2023-2028)
5 Pharmacovigilance Breakdown Data by Application
- 5.1 Global Pharmacovigilance Historic Market Size by Application (2017-2022)
- 5.2 Global Pharmacovigilance Forecasted Market Size by Application (2023-2028)
6 North America
- 6.1 North America Pharmacovigilance Market Size (2017-2028)
- 6.2 North America Pharmacovigilance Market Size by Type
- 6.2.1 North America Pharmacovigilance Market Size by Type (2017-2022)
- 6.2.2 North America Pharmacovigilance Market Size by Type (2023-2028)
- 6.2.3 North America Pharmacovigilance Market Share by Type (2017-2028)
- 6.3 North America Pharmacovigilance Market Size by Application
- 6.3.1 North America Pharmacovigilance Market Size by Application (2017-2022)
- 6.3.2 North America Pharmacovigilance Market Size by Application (2023-2028)
- 6.3.3 North America Pharmacovigilance Market Share by Application (2017-2028)
- 6.4 North America Pharmacovigilance Market Size by Country
- 6.4.1 North America Pharmacovigilance Market Size by Country (2017-2022)
- 6.4.2 North America Pharmacovigilance Market Size by Country (2023-2028)
- 6.4.3 U.S.
- 6.4.4 Canada
7 Europe
- 7.1 Europe Pharmacovigilance Market Size (2017-2028)
- 7.2 Europe Pharmacovigilance Market Size by Type
- 7.2.1 Europe Pharmacovigilance Market Size by Type (2017-2022)
- 7.2.2 Europe Pharmacovigilance Market Size by Type (2023-2028)
- 7.2.3 Europe Pharmacovigilance Market Share by Type (2017-2028)
- 7.3 Europe Pharmacovigilance Market Size by Application
- 7.3.1 Europe Pharmacovigilance Market Size by Application (2017-2022)
- 7.3.2 Europe Pharmacovigilance Market Size by Application (2023-2028)
- 7.3.3 Europe Pharmacovigilance Market Share by Application (2017-2028)
- 7.4 Europe Pharmacovigilance Market Size by Country
- 7.4.1 Europe Pharmacovigilance Market Size by Country (2017-2022)
- 7.4.2 Europe Pharmacovigilance Market Size by Country (2023-2028)
- 7.4.3 Germany
- 7.4.4 France
- 7.4.5 U.K.
- 7.4.6 Italy
- 7.4.7 Russia
- 7.4.8 Nordic Countries
8 Asia-Pacific
- 8.1 Asia-Pacific Pharmacovigilance Market Size (2017-2028)
- 8.2 Asia-Pacific Pharmacovigilance Market Size by Type
- 8.2.1 Asia-Pacific Pharmacovigilance Market Size by Type (2017-2022)
- 8.2.2 Asia-Pacific Pharmacovigilance Market Size by Type (2023-2028)
- 8.2.3 Asia-Pacific Pharmacovigilance Market Share by Type (2017-2028)
- 8.3 Asia-Pacific Pharmacovigilance Market Size by Application
- 8.3.1 Asia-Pacific Pharmacovigilance Market Size by Application (2017-2022)
- 8.3.2 Asia-Pacific Pharmacovigilance Market Size by Application (2023-2028)
- 8.3.3 Asia-Pacific Pharmacovigilance Market Share by Application (2017-2028)
- 8.4 Asia-Pacific Pharmacovigilance Market Size by Region
- 8.4.1 Asia-Pacific Pharmacovigilance Market Size by Region (2017-2022)
- 8.4.2 Asia-Pacific Pharmacovigilance Market Size by Region (2023-2028)
- 8.4.3 China
- 8.4.4 Japan
- 8.4.5 South Korea
- 8.4.6 Southeast Asia
- 8.4.7 India
- 8.4.8 Australia
9 Latin America
- 9.1 Latin America Pharmacovigilance Market Size (2017-2028)
- 9.2 Latin America Pharmacovigilance Market Size by Type
- 9.2.1 Latin America Pharmacovigilance Market Size by Type (2017-2022)
- 9.2.2 Latin America Pharmacovigilance Market Size by Type (2023-2028)
- 9.2.3 Latin America Pharmacovigilance Market Share by Type (2017-2028)
- 9.3 Latin America Pharmacovigilance Market Size by Application
- 9.3.1 Latin America Pharmacovigilance Market Size by Application (2017-2022)
- 9.3.2 Latin America Pharmacovigilance Market Size by Application (2023-2028)
- 9.3.3 Latin America Pharmacovigilance Market Share by Application (2017-2028)
- 9.4 Latin America Pharmacovigilance Market Size by Country
- 9.4.1 Latin America Pharmacovigilance Market Size by Country (2017-2022)
- 9.4.2 Latin America Pharmacovigilance Market Size by Country (2023-2028)
- 9.4.3 Mexico
- 9.4.4 Brazil
10 Middle East & Africa
- 10.1 Middle East & Africa Pharmacovigilance Market Size (2017-2028)
- 10.2 Middle East & Africa Pharmacovigilance Market Size by Type
- 10.2.1 Middle East & Africa Pharmacovigilance Market Size by Type (2017-2022)
- 10.2.2 Middle East & Africa Pharmacovigilance Market Size by Type (2023-2028)
- 10.2.3 Middle East & Africa Pharmacovigilance Market Share by Type (2017-2028)
- 10.3 Middle East & Africa Pharmacovigilance Market Size by Application
- 10.3.1 Middle East & Africa Pharmacovigilance Market Size by Application (2017-2022)
- 10.3.2 Middle East & Africa Pharmacovigilance Market Size by Application (2023-2028)
- 10.3.3 Middle East & Africa Pharmacovigilance Market Share by Application (2017-2028)
- 10.4 Middle East & Africa Pharmacovigilance Market Size by Country
- 10.4.1 Middle East & Africa Pharmacovigilance Market Size by Country (2017-2022)
- 10.4.2 Middle East & Africa Pharmacovigilance Market Size by Country (2023-2028)
- 10.4.3 Turkey
- 10.4.4 Saudi Arabia
- 10.4.5 UAE
11 Key Players Profiles
- 11.1 Eli Lilly and Company
- 11.1.1 Eli Lilly and Company Company Details
- 11.1.2 Eli Lilly and Company Business Overview
- 11.1.3 Eli Lilly and Company Pharmacovigilance Introduction
- 11.1.4 Eli Lilly and Company Revenue in Pharmacovigilance Business (2017-2022)
- 11.1.5 Eli Lilly and Company Recent Developments
- 11.2 ICON
- 11.2.1 ICON Company Details
- 11.2.2 ICON Business Overview
- 11.2.3 ICON Pharmacovigilance Introduction
- 11.2.4 ICON Revenue in Pharmacovigilance Business (2017-2022)
- 11.2.5 ICON Recent Developments
- 11.3 Elsevier
- 11.3.1 Elsevier Company Details
- 11.3.2 Elsevier Business Overview
- 11.3.3 Elsevier Pharmacovigilance Introduction
- 11.3.4 Elsevier Revenue in Pharmacovigilance Business (2017-2022)
- 11.3.5 Elsevier Recent Developments
- 11.4 Chiltern
- 11.4.1 Chiltern Company Details
- 11.4.2 Chiltern Business Overview
- 11.4.3 Chiltern Pharmacovigilance Introduction
- 11.4.4 Chiltern Revenue in Pharmacovigilance Business (2017-2022)
- 11.4.5 Chiltern Recent Developments
- 11.5 Atlantic Research Group
- 11.5.1 Atlantic Research Group Company Details
- 11.5.2 Atlantic Research Group Business Overview
- 11.5.3 Atlantic Research Group Pharmacovigilance Introduction
- 11.5.4 Atlantic Research Group Revenue in Pharmacovigilance Business (2017-2022)
- 11.5.5 Atlantic Research Group Recent Developments
- 11.6 Mapi Group
- 11.6.1 Mapi Group Company Details
- 11.6.2 Mapi Group Business Overview
- 11.6.3 Mapi Group Pharmacovigilance Introduction
- 11.6.4 Mapi Group Revenue in Pharmacovigilance Business (2017-2022)
- 11.6.5 Mapi Group Recent Developments
- 11.7 Accenture
- 11.7.1 Accenture Company Details
- 11.7.2 Accenture Business Overview
- 11.7.3 Accenture Pharmacovigilance Introduction
- 11.7.4 Accenture Revenue in Pharmacovigilance Business (2017-2022)
- 11.7.5 Accenture Recent Developments
- 11.8 Clinquest Group
- 11.8.1 Clinquest Group Company Details
- 11.8.2 Clinquest Group Business Overview
- 11.8.3 Clinquest Group Pharmacovigilance Introduction
- 11.8.4 Clinquest Group Revenue in Pharmacovigilance Business (2017-2022)
- 11.8.5 Clinquest Group Recent Developments
- 11.9 GSK
- 11.9.1 GSK Company Details
- 11.9.2 GSK Business Overview
- 11.9.3 GSK Pharmacovigilance Introduction
- 11.9.4 GSK Revenue in Pharmacovigilance Business (2017-2022)
- 11.9.5 GSK Recent Developments
- 11.10 PRA Health Sciences
- 11.10.1 PRA Health Sciences Company Details
- 11.10.2 PRA Health Sciences Business Overview
- 11.10.3 PRA Health Sciences Pharmacovigilance Introduction
- 11.10.4 PRA Health Sciences Revenue in Pharmacovigilance Business (2017-2022)
- 11.10.5 PRA Health Sciences Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Author Details
- 13.3 Disclaimer